Adverse side effects associated with latanoprost

J. A. Rowe; M. G. Hattenhauer; D. C. Herman

doi:10.1016/S0002-9394(14)70907-9

Adverse side effects associated with latanoprost

J. A. Rowe
, M. G. Hattenhauer
, D. C. Herman

Research output: Contribution to journal › Article › peer-review

94 Scopus citations

Abstract

PURPOSE: To report three different adverse reactions after initiating treatment with latanoprost. METHOD: Serial clinical examinations of three patients were performed. RESULTS: Adverse reactions such as ocular hypotony and choroidal effusions, recurrent cystoid macular edema, and facial rash were noted to occur within 1 to 4 weeks after starting topical latanoprost for the treatment of primary open-angle glaucoma. CONCLUSION: Clinicians should be alerted to these possible complications of topical latanoprost therapy.

Original language	English (US)
Pages (from-to)	683-685
Number of pages	3
Journal	American journal of ophthalmology
Volume	124
Issue number	5
DOIs	https://doi.org/10.1016/S0002-9394(14)70907-9
State	Published - 1997
Externally published	Yes

Bibliographical note

Funding Information:
Mayo Clinic and Mayo Graduate School of Medicine. This study was supported by a grant from the Mayo Foundation, Rochester, Minnesota, and in part by a grant from Research to Prevent Blindness, Inc, New York, New York.

Publisher link

10.1016/S0002-9394(14)70907-9

Find It

Find It at U of M Libraries

Cite this

@article{53487713d0964766a38711b31ad8dcdb,

title = "Adverse side effects associated with latanoprost",

abstract = "PURPOSE: To report three different adverse reactions after initiating treatment with latanoprost. METHOD: Serial clinical examinations of three patients were performed. RESULTS: Adverse reactions such as ocular hypotony and choroidal effusions, recurrent cystoid macular edema, and facial rash were noted to occur within 1 to 4 weeks after starting topical latanoprost for the treatment of primary open-angle glaucoma. CONCLUSION: Clinicians should be alerted to these possible complications of topical latanoprost therapy.",

author = "Rowe, \{J. A.\} and Hattenhauer, \{M. G.\} and Herman, \{D. C.\}",

note = "Funding Information: Mayo Clinic and Mayo Graduate School of Medicine. This study was supported by a grant from the Mayo Foundation, Rochester, Minnesota, and in part by a grant from Research to Prevent Blindness, Inc, New York, New York.",

year = "1997",

doi = "10.1016/S0002-9394(14)70907-9",

language = "English (US)",

volume = "124",

pages = "683--685",

journal = "American journal of ophthalmology",

issn = "0002-9394",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Adverse side effects associated with latanoprost

AU - Rowe, J. A.

AU - Hattenhauer, M. G.

AU - Herman, D. C.

N1 - Funding Information: Mayo Clinic and Mayo Graduate School of Medicine. This study was supported by a grant from the Mayo Foundation, Rochester, Minnesota, and in part by a grant from Research to Prevent Blindness, Inc, New York, New York.

PY - 1997

Y1 - 1997

N2 - PURPOSE: To report three different adverse reactions after initiating treatment with latanoprost. METHOD: Serial clinical examinations of three patients were performed. RESULTS: Adverse reactions such as ocular hypotony and choroidal effusions, recurrent cystoid macular edema, and facial rash were noted to occur within 1 to 4 weeks after starting topical latanoprost for the treatment of primary open-angle glaucoma. CONCLUSION: Clinicians should be alerted to these possible complications of topical latanoprost therapy.

AB - PURPOSE: To report three different adverse reactions after initiating treatment with latanoprost. METHOD: Serial clinical examinations of three patients were performed. RESULTS: Adverse reactions such as ocular hypotony and choroidal effusions, recurrent cystoid macular edema, and facial rash were noted to occur within 1 to 4 weeks after starting topical latanoprost for the treatment of primary open-angle glaucoma. CONCLUSION: Clinicians should be alerted to these possible complications of topical latanoprost therapy.

UR - https://www.scopus.com/pages/publications/0030831374

UR - https://www.scopus.com/pages/publications/0030831374#tab=citedBy

U2 - 10.1016/S0002-9394(14)70907-9

DO - 10.1016/S0002-9394(14)70907-9

M3 - Article

C2 - 9372723

AN - SCOPUS:0030831374

SN - 0002-9394

VL - 124

SP - 683

EP - 685

JO - American journal of ophthalmology

JF - American journal of ophthalmology

IS - 5

ER -

Adverse side effects associated with latanoprost

Abstract

Bibliographical note

Publisher link

Find It

Other files and links

Fingerprint

Cite this